Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1447
https://www.valueinhealthjournal.com/article/S1098-3015(14)03377-4/fulltext
Title :
Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03377-4&doi=10.1016/j.jval.2014.08.1447
First page :
A490
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
930